Creatine Across Your Cycle — and the Bigger Doses for Your Brain

Your hormones really do change how your body handles creatine — that part is biochemistry, not marketing. What almost nobody mentions is that the one trial built to test whether it matters in practice came back nearly empty. The brain research is the more interesting half of the story, and also narrower than the headlines suggest: the doses that moved cognition were four or five times the usual serving, and the brains they moved were sleep-deprived.

If you are starting from zero on creatine — what it is, why midlife, the weight-gain and kidney objections — read "Creatine for Women Over 40" first. This piece picks up two questions that one deliberately left alone.

What estrogen and progesterone do to creatine

Creatine kinase, the enzyme that moves energy between phosphocreatine and ATP, is hormone-sensitive. So is AGAT, the rate-limiting enzyme your body uses to manufacture creatine in the first place — in animal work its expression tracks estrogen and testosterone. Serum creatine kinase runs measurably higher during menstruating years than after them, and drops with age and during pregnancy.

The theory that follows is reasonable. In the luteal phase — the second half of the cycle, when both estrogen and progesterone are high — you break down more protein, store less carbohydrate, and may sustain less muscle damage from hard eccentric work because creatine kinase is partly spared. If your creatine system behaves differently in that half of the month, perhaps supplemental creatine lands differently too.

That is a good hypothesis. It is not a finding.

The trial that actually tested it

In 2023 a research group ran the obvious experiment: 39 active women, randomized and double-blind, five days of a 20 g/day loading dose, tested in both the low-hormone (follicular) and high-hormone (luteal) phase.

Almost everything came back null. Heart rate variability, at rest and in recovery, showed no interaction between supplement and cycle phase. Sprint power favored creatine but not significantly. Exactly one outcome reached significance: during the high-hormone phase, the fatigue index improved 5.8% on creatine against 0.1% on placebo (p = 0.048).

Read that number carefully. It is a single significant result, sitting just under the conventional cutoff, among many outcomes tested, in a study that lost 28% of its participants and pooled naturally cycling women with women on oral contraceptives and IUDs. The authors say all of this themselves, plainly. The honest summary: consistent with the hormone theory, nowhere near strong enough to change what you do.

Why the timing question mostly dissolves in perimenopause

Cycle-timed dosing assumes you know which phase you are in. Perimenopause is defined by cycles that stop being predictable — shorter, then longer, then skipped, then a forty-day gap. Building a supplement schedule on that is building on sand.

The underlying model lets you off the hook anyway. Creatine works by filling a store, not by acting on the day you swallow it: muscle saturation takes roughly four weeks at 3–5 g/day, or five days at 20 g/day. A reservoir does not care what week of the month it is. Take it daily and the phase question stops being a question.

The brain is the part worth arguing about

Your brain stores creatine and spends ATP like muscle does, but it defends its supply far more stubbornly — getting creatine across the blood-brain barrier is slow and inefficient. That, and only that, is the real argument for larger doses. Not "more is better," but "the tissue you are aiming at is the one that takes up least." Reviews of brain saturation suggest something like 15–20 g/day for several days, then a steady 5–10 g/day — well above the 3–5 g that saturates muscle.

What the bigger doses did in trials

Two studies, two very different answers.

In sleep-deprived brains, quite a lot. In a 2024 trial, 15 healthy adults — 8 of them women — took a single dose of 0.35 g/kg, roughly 25 g for a 70 kg person, during a night of sleep deprivation. Word memory improved about 10% over placebo. Processing speed improved on language, logic and numeric tasks. Brain imaging showed phosphocreatine holding steady and brain pH stabilizing where placebo drifted. The effect peaked around four hours after the dose and faded over roughly nine.

In rested brains, nothing. A six-week trial compared 10 g/day, 20 g/day and placebo in 30 healthy young adults across processing speed, episodic memory and executive function. Creatine had no significant effect at either dose, and no dose-response. The authors note they never measured brain creatine directly, so they cannot prove the supplement even reached the tissue.

Together those results sketch the pattern worth remembering: creatine appears to help a brain that is short on energy, and does nothing measurable for a brain that isn't. One small acute study on one side, one cleaner null trial on the other. That is why this piece carries the weakest evidence label we use — the biology is plausible, the human outcome data barely exists.

It is also, admittedly, the reason the idea is interesting in midlife. Broken sleep and the brain fog that comes with it are not a side note in perimenopause; they are the main complaint. A compound that only helps an energy-stressed brain is being tested, in your case, under exactly the conditions where it might do something.

What a bigger dose costs

Twenty-five grams of creatine is five servings, and it behaves like five servings. Nausea, diarrhea and general gastrointestinal distress are the common complaints; the NIH fact sheet also lists muscle cramps, stiffness and heat intolerance, and notes creatine typically adds 1–2 kg of body weight in a month as water is pulled into muscle. Hydration matters more at these doses, not less. It also costs five times as much.

None of that is dangerous in a healthy adult — creatine has years of safety data behind it, including long-term use — but it is not free, and the loading phase is where nearly all the complaints come from.

When to talk to a doctor

• Kidney disease or reduced kidney function — before starting, at any dose.
• Pregnant or breastfeeding — there isn't enough data to say, which is not the same as a known risk, but it is a conversation.
• Before routine bloodwork — creatine raises serum creatinine, the marker used to estimate kidney function. Mention that you take it, or healthy kidneys can look abnormal on paper.

What we would actually do

Take 3–5 g of creatine monohydrate daily and stop thinking about your cycle. The hormone biology is real, the practical payoff is unproven, and in perimenopause the phases are too unreliable to dose against even if it worked.

If the brain claim is what draws you, treat it as a bounded experiment rather than a protocol: a larger dose on a specific badly-slept day, and honest attention to whether the afternoon actually goes better. The evidence for that is one small acute study. The evidence against taking a high dose every day in the hope of a sharper rested brain is a cleaner trial that found nothing.

And it may simply not do anything for you. That is a legitimate result, and it costs very little to find out at the ordinary dose first.